瘤微环境营养素,细胞反应和癌症
Graham P Lobel1, Yanqing Jiang1, M Celeste Simon2
1Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cell chemical biology
|September 13, 2023
概括
癌细胞及其周围的微环境依赖于营养的可用性来实现生长和生存. 了解营养对瘤新陈代谢的影响,为治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 瘤微环境 瘤微环境
背景情况:
- 重编程瘤代谢对于癌症的进展至关重要.
- 营养素的可用性显著影响癌细胞代谢途径.
- 瘤微环境 (TME) 在支持恶性转变方面发挥着至关重要的作用.
研究的目的:
- 审查当前对营养可用性对癌症代谢重编程影响的理解.
- 探索营养物质如何影响TME内的癌细胞和树皮细胞.
- 为了确定这些代谢相互作用产生的潜在的治疗漏洞.
主要方法:
- 关于瘤代谢的最新进展的文献综述.
- 对营养-代谢通路相互作用的主要例子的分析.
- 在TME中控制细胞活动的调节机制的剖析.
主要成果:
- 营养素的可用性深深地影响了癌症和树皮细胞的代谢途径.
- 在TME内的代谢重编程对于瘤生长和进展至关重要.
- 特定的营养素和代谢酶调节免疫,纤维细胞和内皮细胞的行为.
结论:
- 了解TME中依赖营养的代谢重编程是癌症治疗的关键.
- 针对营养的可用性和代谢途径提供了新的治疗机会.
- 利用瘤生态系统中的代谢漏洞可以导致更有效的癌症疗法.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K


